Ngā hua rapu - Patrick Yu‐Wai‐Man

Whakamahine hua
  1. 1
    Leber hereditary optic neuropathy

    Leber hereditary optic neuropathy mā Patrick Yu Wai Man

    I whakaputaina 2002
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Traumatic optic neuropathy—Clinical features and management issues

    Traumatic optic neuropathy—Clinical features and management issues mā Patrick Yu‐Wai‐Man

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Genetic manipulation for inherited neurodegenerative diseases: myth or reality?

    Genetic manipulation for inherited neurodegenerative diseases: myth or reality? mā Patrick Yu‐Wai‐Man

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Leber hereditary optic neuropathy

    Leber hereditary optic neuropathy mā Neringa Jurkutė, Patrick Yu‐Wai‐Man

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Surgery for traumatic optic neuropathy

    Surgery for traumatic optic neuropathy mā Patrick Yu‐Wai‐Man, Philip G. Griffiths

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Steroids for traumatic optic neuropathy

    Steroids for traumatic optic neuropathy mā Patrick Yu‐Wai‐Man, Philip G. Griffiths

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Dominant Optic Atrophy: Novel OPA1 Mutations and Revised Prevalence Estimates

    Dominant Optic Atrophy: Novel OPA1 Mutations and Revised Prevalence Estimates mā Patrick Yu‐Wai‐Man, Patrick F. Chinnery

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Inherited eye-related disorders due to mitochondrial dysfunction

    Inherited eye-related disorders due to mitochondrial dysfunction mā Patrick Yu‐Wai‐Man, Nancy J. Newman

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Developments in the Treatment of Leber Hereditary Optic Neuropathy

    Developments in the Treatment of Leber Hereditary Optic Neuropathy mā Benson Chen, Patrick Yu‐Wai‐Man, Nancy J. Newman

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Mitochondrial optic neuropathies – Disease mechanisms and therapeutic strategies

    Mitochondrial optic neuropathies – Disease mechanisms and therapeutic strategies mā Patrick Yu‐Wai‐Man, Philip G. Griffiths, Patrick F. Chinnery

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Treatment strategies for inherited optic neuropathies: past, present and future

    Treatment strategies for inherited optic neuropathies: past, present and future mā Patrick Yu‐Wai‐Man, Marcela Votruba, Anthony T. Moore, Patrick F. Chinnery

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Understanding the molecular basis and pathogenesis of hereditary optic neuropathies: towards improved diagnosis and management

    Understanding the molecular basis and pathogenesis of hereditary optic neuropathies: towards improved diagnosis and management mā Nancy J. Newman, Patrick Yu‐Wai‐Man, Valérie Biousse, Valério Carelli

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Inherited mitochondrial optic neuropathies

    Inherited mitochondrial optic neuropathies mā Patrick Yu‐Wai‐Man, Philip G. Griffiths, Gavin Hudson, Patrick F. Chinnery

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Evaluating the therapeutic potential of idebenone and related quinone analogues in Leber hereditary optic neuropathy

    Evaluating the therapeutic potential of idebenone and related quinone analogues in Leber hereditary optic neuropathy mā Patrick Yu‐Wai‐Man, Devorah Soiferman, David Moore, Florence Burté, Ann Saada

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Humoral immune responses to <scp>AAV</scp> gene therapy in the ocular compartment

    Humoral immune responses to <scp>AAV</scp> gene therapy in the ocular compartment mā M. A. Whitehead, Andrew Osborne, Patrick Yu‐Wai‐Man, Keith R. Martin

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Retinal Ganglion Cells—Diversity of Cell Types and Clinical Relevance

    Retinal Ganglion Cells—Diversity of Cell Types and Clinical Relevance mā Ungsoo Samuel Kim, Omar A. Mahroo, J. D. Mollon, Patrick Yu‐Wai‐Man

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Mitochondria and the eye—manifestations of mitochondrial diseases and their management

    Mitochondria and the eye—manifestations of mitochondrial diseases and their management mā Benson Chen, Joshua Harvey, Michael James Gilhooley, Neringa Jurkutė, Patrick Yu‐Wai‐Man

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Pattern of retinal ganglion cell loss in dominant optic atrophy due to OPA1 mutations

    Pattern of retinal ganglion cell loss in dominant optic atrophy due to OPA1 mutations mā Patrick Yu‐Wai‐Man, Maura Bailie, Alaa Atawan, Patrick F. Chinnery, Philip G. Griffiths

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations

    Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations mā Gerald Pfeffer, Ailbhe Burke, Patrick Yu‐Wai‐Man, D. A. S. Compston, Patrick F. Chinnery

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Angiopoietins in Diabetic Retinopathy: Current Understanding and Therapeutic Potential

    Angiopoietins in Diabetic Retinopathy: Current Understanding and Therapeutic Potential mā M. A. Whitehead, Andrew Osborne, Peter Widdowson, Patrick Yu‐Wai‐Man, Keith R. Martin

    I whakaputaina 2019
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: